Skip to main content
GutCited

Curcumin untuk Crohn's Disease

C

Limited RCT evidence. Some improvement in CDAI scores but results inconsistent. Better evidence exists for UC than Crohn's.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Kesimpulan

Limited RCT evidence. Some improvement in CDAI scores but results inconsistent. Better evidence exists for UC than Crohn's.

Key Study Findings

Meta-Analysis n=2260
Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: …
Dose: None vs: placebo or other medical therapies Outcome: endoscopic recurrence (Rutgeerts score >= i2) at 6 … Efek: adalimumab vs thiopurines OR 0.33 (95% CI 0.12-0.91); adalimumab vs vitamin D OR 0.07 (95% CI 0.01-0 None

Populasi: patients with Crohn's disease post-surgery from 42 studies (38 RCTs)

Meta-Analysis
Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of …
Dose: Varying dosages vs: Placebo Outcome: Clinical remission and response in UC Efek: None None

Populasi: UC and CD patients (13 RCTs)

Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others vs: Standard care or placebo Outcome: Symptom improvement in GI diseases Efek: None None

Populasi: Patients with gastroenterological diseases

Review
Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.
Dose: Curcumin nanoformulations vs: None Outcome: IBD symptom improvement Efek: None None

Populasi: IBD patients (preclinical/clinical review)

Review
Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and …
Dose: Various phytochemicals vs: None Outcome: NF-kB regulation in IBD Efek: None None

Populasi: In vitro and in vivo IBD models

Meta-Analysis
Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A …
Dose: None vs: Placebo or standard care Outcome: Clinical/laboratory outcomes in autoimmune diseases Efek: None None

Populasi: Patients with 10 types of autoimmune diseases

Key Statistics

3

Studi

200

Peserta

Mixed

C

Peringkat

Referenced Papers

European journal of … 2021 40 sitasi
Journal of medicinal … 2019 17 sitasi
Current opinion in … 2019 5 sitasi
Gastroenterology clinics of … 2018 67 sitasi
Complementary therapies in … 2017 23 sitasi
The Medical clinics … 2017 9 sitasi
Annals of gastroenterology 2015 135 sitasi
Alimentary pharmacology & … 2013 128 sitasi
Nature reviews. Gastroenterology … 2013 47 sitasi
Digestive diseases and … 2005 461 sitasi
Bioinformatics (Oxford, England) 2004 149 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:
500-1,500 mg/day with piperine (black pepper extract) for absorption
ibssupport:
500-1,000 mg/day
ucmaintenance:
2,000 mg/day (1 g twice daily) as adjunct to mesalamine

Batas atas: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None -- Positive 2260
Varying dosages -- Positive --
Peppermint oil, STW-5, psyllium, others -- Positive --
Curcumin nanoformulations -- Positive --
Various phytochemicals -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Waktu terbaik diminum: With meals containing fat and black pepper for enhanced absorption

Safety & Side Effects

Efek Samping yang Dilaporkan

  • GI discomfort (nausea, diarrhea, abdominal pain) at high doses
  • Yellow staining of skin/teeth with topical/oral contact
  • Increased gallbladder contractions (avoid with gallstones or bile duct obstruction)
  • Iron chelation (may reduce iron absorption at very high doses)

Interaksi yang Diketahui

  • Anticoagulants (curcumin has antiplatelet properties; may increase bleeding risk)
  • Chemotherapy agents (curcumin may alter drug metabolism via CYP enzyme inhibition)
  • Sulfasalazine (additive anti-inflammatory effect — may be beneficial in IBD)
  • Iron supplements (curcumin may chelate iron; space dosing)
  • Piperine/black pepper (enhances curcumin bioavailability by 2,000% — commonly co-administered)

Asupan atas yang dapat ditoleransi: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Curcumin help with Crohn's Disease?
Based on 3 studies with 200 participants, there is limited but promising evidence that Curcumin may support Crohn's Disease management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for Crohn's Disease?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day with piperine (black pepper extract) for absorption. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include GI discomfort (nausea, diarrhea, abdominal pain) at high doses, Yellow staining of skin/teeth with topical/oral contact, Increased gallbladder contractions (avoid with gallstones or bile duct obstruction), Iron chelation (may reduce iron absorption at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Crohn's Disease?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is mixed.

Related Evidence

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.